71866-22-3 Usage
Uses
Used in Pharmaceutical Synthesis:
1-(2,3,4,5,6,7-hexahydro-1H-cyclopenta[b]pyridin-1-yl)ethanone is used as an intermediate in the synthesis of various organic compounds and pharmaceuticals. Its unique structure allows for the creation of a wide range of molecules with different therapeutic properties.
Used in Medicine:
1-(2,3,4,5,6,7-hexahydro-1H-cyclopenta[b]pyridin-1-yl)ethanone is studied for its potential pharmacological properties, including its role as a potential analgesic and anticonvulsant. Its ability to alleviate pain and prevent seizures could make it a valuable addition to the medical field.
Used in Anticancer Research:
1-(2,3,4,5,6,7-hexahydro-1H-cyclopenta[b]pyridin-1-yl)ethanone has also been investigated for its potential to inhibit the growth of cancer cells. Its ability to target and disrupt cancer cell growth could lead to the development of new cancer treatments and contribute to the fight against various types of cancer.
Used in Drug Development:
Overall, 1-(2,3,4,5,6,7-hexahydro-1H-cyclopenta[b]pyridin-1-yl)ethanone is a versatile chemical with potential applications in various fields, including medicine and drug development. Its unique structure and properties make it a promising candidate for further research and development in the pharmaceutical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 71866-22-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,1,8,6 and 6 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 71866-22:
(7*7)+(6*1)+(5*8)+(4*6)+(3*6)+(2*2)+(1*2)=143
143 % 10 = 3
So 71866-22-3 is a valid CAS Registry Number.
71866-22-3Relevant academic research and scientific papers
ENAMINE CHEMISTRY-XXV REDUCTION OF ENAMINONONES BY LiAlH4 AND NaBH4 SYNTHESIS OF α,β-UNSATURATED ALDEHYDES
Carlsson, S.,Lawesson, S.-O.
, p. 413 - 417 (2007/10/02)
Cyclohexanone, 2-methyl-cyclohexanone and 4-methyl-cyclohexanone, 1, were transformed into the enaminones 4a-4e by the following two routes: (A): Acylation of the enamines, 2, derived from 1 and secondary amines (pyrrolidine, morpholine and piperidine) by ethyl chloroformate, and (B): Condensation of 1 with diethyl oxalate, giving the β-ketoesters 3, followed by reaction with the secondary amines.Ethyl 2(-1-pyrrolidinyl)-1-cyclopentene-1-carboxylate. 4f, and methyl 3-(1-pyrrolidinyl)-2-buteonate, 4g, were prepared from ethyl 2-oxo-1-cyclopentanecarboxylate and ethyl 3-oxo-butanoate, respectively, by condensation with pyrrolidine.Reduction of 4a by LAH afforded 1-cyclohexen-1-carboxaldehyde, 5a, 1-cyclohexene-1-methanol, 6a, and 1-(1-cyclohexene-1-methyl)pyrrolidine, 7a, in yields depending on the molar ratio of LAH/4a.Reduction of 4f by LAH gave cyclopenten-1-methanol, 6b, 1-(1-cyclopentene-1-methyl)pyrrolidine, 7b, and ethyl-2(1-pyrrolidinyl)-1-cyclopentanecarboxylate, 8b.Compound 4g, when reduced with LAH, yielded methyl 3-(1-pyrrolidinyl) butanoate, 8c (main product) and 1-(2-butenyl)pyrrolidine, 7c (minor).Reduction of 4 by NaBH4 afforded exlusively the saturated β-aminoesters, 8, in high yields.The reductions with LAH and NaBH4 are rationalized in terms of the HSAB principle.
